DNA damage and transcriptional regulation in iPSC-derived neurons from Ataxia Telangiectasia patients.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
24 01 2019
Historique:
received: 06 09 2018
accepted: 23 11 2018
entrez: 26 1 2019
pubmed: 27 1 2019
medline: 8 8 2020
Statut: epublish

Résumé

Ataxia Telangiectasia (A-T) is neurodegenerative syndrome caused by inherited mutations inactivating the ATM kinase, a master regulator of the DNA damage response (DDR). What makes neurons vulnerable to ATM loss remains unclear. In this study we assessed on human iPSC-derived neurons whether the abnormal accumulation of DNA-Topoisomerase 1 adducts (Top1ccs) found in A-T impairs transcription elongation, thus favoring neurodegeneration. Furthermore, whether neuronal activity-induced immediate early genes (IEGs), a process involving the formation of DNA breaks, is affected by ATM deficiency. We found that Top1cc trapping by CPT induces an ATM-dependent DDR as well as an ATM-independent induction of IEGs and repression especially of long genes. As revealed by nascent RNA sequencing, transcriptional elongation and recovery were found to proceed with the same rate, irrespective of gene length and ATM status. Neuronal activity induced by glutamate receptors stimulation, or membrane depolarization with KCl, triggered a DDR and expression of IEGs, the latter independent of ATM. In unperturbed A-T neurons a set of genes (FN1, DCN, RASGRF1, FZD1, EOMES, SHH, NR2E1) implicated in the development, maintenance and physiology of central nervous system was specifically downregulated, underscoring their potential involvement in the neurodegenerative process in A-T patients.

Identifiants

pubmed: 30679601
doi: 10.1038/s41598-018-36912-0
pii: 10.1038/s41598-018-36912-0
pmc: PMC6346060
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

651

Références

Clin Cancer Res. 2004 May 1;10(9):2922-7
pubmed: 15131026
Nature. 2004 Jun 24;429(6994):883-91
pubmed: 15190254
Neuroscience. 2006 Feb;137(3):1031-7
pubmed: 16289828
DNA Repair (Amst). 2008 Jul 1;7(7):1010-27
pubmed: 18458000
Genes Dev. 2008 Sep 15;22(18):2479-84
pubmed: 18794345
PLoS One. 2010 Jan 29;5(1):e8962
pubmed: 20126412
Proc Natl Acad Sci U S A. 2010 May 25;107(21):9736-41
pubmed: 20460306
Nat Methods. 2011 May;8(5):409-12
pubmed: 21460823
Neuropathology. 2012 Jun;32(3):234-44
pubmed: 22017321
Nat Protoc. 2012 Mar 01;7(3):562-78
pubmed: 22383036
Autophagy. 2012 May 1;8(5):840-1
pubmed: 22617444
J Clin Invest. 2012 Oct;122(10):3593-602
pubmed: 22996661
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Neurobiol Aging. 2013 Jun;34(6):1653-61
pubmed: 23273601
Nature. 2013 Jan 17;493(7432):327-37
pubmed: 23325215
Nat Neurosci. 2013 May;16(5):613-21
pubmed: 23525040
PLoS One. 2013 Apr 23;8(4):e58239
pubmed: 23626666
DNA Repair (Amst). 2013 Aug;12(8):605-11
pubmed: 23707302
Nature. 2013 Sep 5;501(7465):58-62
pubmed: 23995680
Front Cell Neurosci. 2013 Oct 07;7:175
pubmed: 24109433
J Neurochem. 2014 Mar;128(6):841-51
pubmed: 24117848
Nat Neurosci. 2014 Jun;17(6):813-21
pubmed: 24793032
Proc Natl Acad Sci U S A. 2014 Jun 24;111(25):9115-20
pubmed: 24927526
Cell Death Dis. 2014 Jul 17;5:e1342
pubmed: 25032865
Methods Mol Biol. 2015;1206:69-80
pubmed: 25240887
Stem Cell Reports. 2015 Apr 14;4(4):727-43
pubmed: 25772473
Cell. 2015 Jun 18;161(7):1592-605
pubmed: 26052046
BMC Genomics. 2015;16 Suppl 8:S2
pubmed: 26110515
Nat Cell Biol. 2015 Oct;17(10):1259-1269
pubmed: 26344566
Science. 2015 Oct 2;350(6256):94-98
pubmed: 26430121
Cell Mol Life Sci. 2016 Jan;73(2):291-303
pubmed: 26499980
Oncol Lett. 2015 Sep;10(3):1769-1774
pubmed: 26622748
Nat Commun. 2015 Dec 16;6:10191
pubmed: 26671524
Nat Commun. 2016 Mar 31;7:11173
pubmed: 27029645
Cell. 2016 Apr 7;165(2):357-71
pubmed: 27058666
Nat Rev Neurosci. 2016 Jul;17(7):424-37
pubmed: 27194476
PLoS One. 2016 May 27;11(5):e0156439
pubmed: 27231886
Genomics Proteomics Bioinformatics. 2016 Jun;14(3):155-165
pubmed: 27245308
Elife. 2016 Jun 15;5:
pubmed: 27304073
Nat Rev Mol Cell Biol. 2016 Nov;17(11):703-721
pubmed: 27649880
Orphanet J Rare Dis. 2016 Nov 25;11(1):159
pubmed: 27884168
Nucleic Acids Res. 2017 Jan 4;45(D1):D183-D189
pubmed: 27899595
Cell Rep. 2017 Jan 3;18(1):122-135
pubmed: 28052243
Dev Dyn. 2018 Jan;247(1):33-46
pubmed: 28543935
Philos Trans R Soc Lond B Biol Sci. 2017 Oct 5;372(1731):
pubmed: 28847820
Science. 2018 Feb 2;359(6375):555-559
pubmed: 29217584
Nat Neurosci. 2018 Jan;21(1):120-129
pubmed: 29230054
Mol Cell Neurosci. 2018 Mar;87:27-34
pubmed: 29254824
Proc Natl Acad Sci U S A. 2018 Jan 9;115(2):E292-E301
pubmed: 29279380
Sci Signal. 2018 Jan 09;11(512):null
pubmed: 29317520

Auteurs

Alessandro Corti (A)

Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Via Amadeo 42, 20133, Milano, Italy.

Raina Sota (R)

Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Via Amadeo 42, 20133, Milano, Italy.

Matteo Dugo (M)

Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale Tumori, Via Amadeo 42, 20133, Milano, Italy.

Raffaele A Calogero (RA)

Universita' degli Studi di Torino, Bioinformatics and Genomics Unit, Molecular Biotechnology Centre, Via Nizza 52, 10126, Torino, Italy.

Benedetta Terragni (B)

Fondazione IRCCS Istituto Neurologico Carlo Besta, Department of Neurophysiopathology and Diagnostic Epileptology, Via Celoria 11, 20133, Milano, Italy.

Massimo Mantegazza (M)

Institute of Molecular and Cellular Pharmacology (IPMC) LabEx ICST, CNRS UMR7275, Route des Lucioles, 06560, Valbonne, Sophia Antipolis, France.
University Côte d'Azur, 660 Route des Lucioles, 06560, Valbonne, Sophia Antipolis, France.

Silvana Franceschetti (S)

Fondazione IRCCS Istituto Neurologico Carlo Besta, Department of Neurophysiopathology and Diagnostic Epileptology, Via Celoria 11, 20133, Milano, Italy.

Michela Restelli (M)

Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Via Amadeo 42, 20133, Milano, Italy.

Patrizia Gasparini (P)

Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Via G Venezian 1, 20133, Milano, Italy.

Daniele Lecis (D)

Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Via Amadeo 42, 20133, Milano, Italy.

Krystyna H Chrzanowska (KH)

Department of Medical Genetics, The Children's Memorial Health Institute, Al. Dzieci Polskich 20, 04-730, Warsaw, Poland.

Domenico Delia (D)

Department of Research, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Via Amadeo 42, 20133, Milano, Italy. domenico.delia@ifom.eu.
IFOM, FIRC Institute of Molecular Oncology, Via Adamello 16, 20139, Milano, Italy. domenico.delia@ifom.eu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH